The Business Times
SUBSCRIBERS

Drugmaker Shire offers to buy Baxalta for US$30b

Published Wed, Aug 5, 2015 · 09:50 PM

London

IRISH drugmaker Shire said on Tuesday that it had offered to buy the biopharmaceutical company Baxalta in an all-stock deal worth about US$30 billion.

Shire said on Tuesday that it had approached Baxalta in early July about a potential combination, but Baxalta concluded, following a written proposal on July 31, not to proceed with discussions.

BT is now on Telegram!

For daily updates on weekdays and specially selected content for the weekend. Subscribe to  t.me/BizTimes

Consumer & Healthcare

SUPPORT SOUTH-EAST ASIA'S LEADING FINANCIAL DAILY

Get the latest coverage and full access to all BT premium content.

SUBSCRIBE NOW

Browse corporate subscription here